This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Identify Down syndrome transcriptome associations using integrative analysis of microarray database and correlation-interaction network
Human Genomics Open Access 19 January 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Galmarini CM, Mackey JR, Dumontet C . Nucleoside analogues: mechanisms of drug resistance and reversal strategies. Leukemia 2001; 15: 875–890.
Galmarini CM, Thomas X, Graham K, El Jafaari A, Cros E, Jordheim L et al. Deoxycytidine kinase and cN-II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine. Br J Haematol 2003; 122: 53–60.
Veuger MJ, Honders MW, Willemze R, Barge RM . Deoxycytidine kinase expression and activity in patients with resistant versus sensitive acute myeloid leukemia. Eur J Haematol 2002; 69: 171–178.
Chen EH, Johnson EE, Vetter SM, Mitchell BS . Characterization of the deoxycytidine kinase promoter in human lymphoblast cell lines. J Clin Invest 1995; 95: 1660–1668.
Ge Y, Jensen TL, Matherly LH, Taub JW . Physical and functional interactions between usf and sp1 proteins regulate human deoxycytidine kinase promoter activity. J Biol Chem 2003; 278: 49901–49910.
Ge Y, Stout ML, Tatman DA, Jensen TL, Buck S, Thomas RL et al. GATA1, cytidine deaminase and the high cure rate of Down syndrome children with acute megakaryocytic leukemia. J Natl Cancer Inst 2005; 97: 226–231.
Taub JW, Huang X, Matherly LH, Stout ML, Buck SA, Massey GV et al. Expression of chromosome 21-localized genes in acute myeloid leukemia: differences between Down Syndrome and non-Down Syndrome blast cells and relationship to in vitro sensitivity to cytosine arabinoside and daunorubicin. Blood 1999; 94: 1393–1400.
Ge Y, Jensen TL, Stout ML, Flatley RM, Grohar P, Ravindranath Y et al. The role of cytidine deaminase and GATA1 mutations in the increased cytosine arabinoside sensitivity of Down syndrome myeloblasts and leukemia cell lines. Cancer Res 2004; 64: 728–735.
Acknowledgements
This work was supported by grant RO1 CA92308 from the National Cancer Institute, The Leukemia and Lymphoma Society, Children's Research Center of Michigan, BPCT and Justin's Gift Golf Charities, The Elana Fund and Leukemia, Research, Life, Inc. JWT is a Scholar in Clinical Research of the Leukemia and Lymphoma Society. YG is a recipient of the National Down Syndrome Society's Charles J Epstein Research Award and the Children's Research Center of Michigan Research Award.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ge, Y., Jensen, T., Tatman, D. et al. Role of USF1 in the differential expression of the human deoxycytidine kinase gene in acute myeloid leukemia. Leukemia 19, 677–679 (2005). https://doi.org/10.1038/sj.leu.2403666
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403666